An evaluation of calprotectin as serum marker of preeclampsia: a systematic review of observational studies
- 334 Downloads
Calprotectin is calcium-binding protein which can be found in the cytosol of neutrophils. Several studies have studied its levels in preeclamptic women; however, to date there is no consensus regarding its effectiveness in the field.
To investigate whether serum calprotectin levels are elevated among preeclamptic women compared to healthy controls.
Materials and methods
We used Medline (1966–2015), Scopus (2004–2015), ClinicalTrials.gov (2008–2015), Cochrane Central Register of Controlled Trials CENTRAL (1999–2015) and Google Scholar (2004–2015) search engines in our primary search, together with reference lists from included studies.
Seven studies were finally included in our systematic review which recruited 439 women (245 with preeclampsia and 194 healthy controls). Their methodological quality was relatively high as they reached a score that ranged between 6 and 7 according to the Ottawa–Newcastle classification. All included studies reported that the serum calprotectin levels were significantly elevated among preeclamptic patients (p < 0.05). One study suggested that patients with severe preeclampsia have significantly higher levels of calprotectin than patients with mild preeclampsia (p = 0.01). However, to date there is no evidence regarding specific cut-off values which would help screen women for preeclampsia, or even follow the course of the disease.
Current evidence suggests that serum calprotectin is significantly raised among women with preeclampsia during the third trimester. Future research is needed to reach firm conclusions regarding its use as a potential screening and surveillance marker during the pregnancy course of women at risk of developing preeclampsia.
KeywordsCalprotectin Pregnancy Preeclampsia S100A8/A9 Calgranulin
Compliance with ethical standards
The authors report they did not receive funding for the present paper.
Conflict of interest
None for all authors.
- 11.Zhou Y, McMaster M, Woo K, Janatpour M, Perry J, Karpanen T, et al. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol. 2002;160:1405–23.PubMedPubMedCentralCrossRefGoogle Scholar
- 13.Sahay AS, Sundrani DP, Joshi SR. Regional changes of placental vascularization in preeclampsia: a review. IUBMB Life 2015.Google Scholar
- 20.Wells GA, Shea B, O’Connel D, Peterson J, V W, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis. www.ohri.ca/programs/clinical_epidemiology/oxford.asp, 2011.
- 23.Akcum S, Zulfikaroglu E, Eserdag S, Ozcan U. Plasma Calprotectin Levels in Preeclamptic Normotensive Pregnant and Nonpregnant Women. 2014.Google Scholar
- 26.Börekçi B, Aksoy H, Öztürk N, Kadanalı S. Correlation between calprotectin and oxidized LDL in preeclampsia. Turk J Med Sci. 2009;39:191–5.Google Scholar
- 29.Zaid O, Abdel-Maksoud H, Elmagid A, Omnia M. Biochemical effect of pre eclampsia on serum calprotectin, ascorbic acid, Uric Acid and Calcium. Benha Veterinary Med J. 2014;27(2):217–24.Google Scholar
- 34.Nakashige TG, Zhang B, Krebs C, Nolan EM. Human calprotectin is an iron-sequestering host-defense protein. Nat Chem Biol 2015.Google Scholar
- 37.Espinoza J, Chaiworapongsa T, Romero R, Edwin S, Rathnasabapathy C, Gomez R, et al. Antimicrobial peptides in amniotic fluid: defensins, calprotectin and bacterial/permeability-increasing protein in patients with microbial invasion of the amniotic cavity, intra-amniotic inflammation, preterm labor and premature rupture of membranes. J Matern Fetal Neonatal Med. 2003;13:2–21.PubMedCrossRefGoogle Scholar